Clinical Trial Update: Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases [NA]

View source ↗

Summary

Clinical trial update describing a radioiodine dosimetry protocol for metastatic thyroid cancer; no phase or results are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Thyroid Carcinoma, Metastatic Sites Lung Bone Nodal | NA | Status: UNKNOWN